VARIABLE | FREQUENCY (%) |
Sex |
|
Male | 10 (83.33) |
Female | 2 (16.67) |
Age (years) |
|
≤60 | 6 (50) |
>60 | 6 (50) |
Tumor size (cm) |
|
≤3 | 6 (50) |
>3 | 6 (50) |
Neoadjuvant chemotherapy |
|
Yes | 4 (33.33) |
No | 8 (66.67) |
Postoperative histology |
|
pT2G3N0M0 | 6 (50) |
pT2G2N0M0 | 3 (25) |
pT3G2N1M0 | 2 (16.67) |
pT2G3N1M0 | 1 (8.33) |
ASA classification |
|
Grade 3 | 6 (50) |
Grade 2 | 5 (41.67) |
Grade 1 | 1 (8.33) |
Tumor location |
|
Right lateral surface of the bladder | 3 (25) |
Left lateral surface of the bladder | 2 (16.67) |
Both lateral surfaces of the bladder | 1 (8.33) |
Dome of the bladder | 1 (8.33) |
Bladder neck/prostatic urethra | 1 (8.33) |
Bladder neck/anterior surface of the bladder | 1 (8.33) |
Left lateral surface/anterior surface of the bladder | 1 (8.33) |
Right meatus/right lateral surface | 1 (8.33) |
Left meatus/left pelvis | 1 (8.33) |